RA
NRC icon

Royce & Associates’s NRC Health Common Stock NRC Stock Holding History

Royce & Associates’s Portfolio NRC Stock Details NRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-61,581
Closed -$1.41M – 880
2024
Q3 		$1.41M Hold
61,581
– – 0.01% 677
2024
Q2 		$1.41M Sell
61,581
-12,447
-17% -$384K 0.01% 667
2024
Q1 		$2.93M Buy
74,028
+439
+0.6% +$17.4K 0.03% 586
2023
Q4 		$2.91M Buy
73,589
+25,000
+51% +$1.05M 0.03% 595
2023
Q3 		$2.16M Buy
48,589
+128
+0.3% +$5.59K 0.02% 632
2023
Q2 		$2.11M Sell
48,461
-69
-0.1% -$3.03K 0.02% 660
2023
Q1 		$2.11M Sell
48,530
-132
-0.3% -$5.83K 0.02% 648
2022
Q4 		$1.82M Buy
48,662
+265
+0.5% +$10.3K 0.02% 662
2022
Q3 		$1.93M Buy
48,397
+179
+0.4% +$6.63K 0.02% 633
2022
Q2 		$1.85M Buy
48,218
+24
+0% +$868 0.02% 671
2022
Q1 		$1.91M Buy
48,194
+48
+0.1% +$1.88K 0.02% 717
2021
Q4 		$2M Buy
48,146
+1,478
+3% +$64.3K 0.01% 728
2021
Q3 		$1.97M Hold
46,668
– – 0.01% 740
2021
Q2 		$2.14M Hold
46,668
– – 0.01% 753
2021
Q1 		$2.19M Sell
46,668
-57,930
-55% -$2.82M 0.01% 744
2020
Q4 		$4.47M Sell
104,598
-53,263
-34% -$2.73M 0.04% 568
2020
Q3 		$7.77M Sell
157,861
-15,498
-9% -$858K 0.08% 355
2020
Q2 		$10.1M Buy
173,359
+89
+0.1% +$4.7K 0.11% 265
2020
Q1 		$7.88M Sell
173,270
-5,189
-3% -$312K 0.11% 252
2019
Q4 		$11.8M Sell
178,459
-38,359
-18% -$2.34M 0.11% 275
2019
Q3 		$12.5M Buy
216,818
+159
+0.1% +$9.85K 0.12% 254
2019
Q2 		$12.5M Sell
216,659
-10,188
-4% -$471K 0.11% 264
2019
Q1 		$8.76M Buy
226,847
+173
+0.1% +$6.78K 0.07% 371
2018
Q4 		$8.64M Sell
226,674
-3,658
-2% -$141K 0.08% 364
2018
Q3 		$8.89M Buy
230,332
+224
+0.1% +$8.49K 0.06% 439
2018
Q2 		$8.61M Buy
230,108
+5,109
+2% +$178K 0.06% 438
2018
Q1 		$6.58M Buy
224,999
+10
+0% +$335 0.05% 487
2017
Q4 		$8.39M Sell
224,989
-15,677
-7% -$557K 0.06% 446
2017
Q3 		$9.07M Buy
240,666
+249
+0.1% +$7.82K 0.06% 411
2017
Q2 		$6.47M Buy
240,417
+115,532
+93% +$2.82M 0.04% 505
2017
Q1 		$2.46M Buy
124,885
+84,852
+212% +$1.57M 0.02% 797
2016
Q4 		$761K Hold
40,033
– – ﹤0.01% 971
2016
Q3 		$652K Hold
40,033
– – ﹤0.01% 975
2016
Q2 		$548K Hold
40,033
– – ﹤0.01% 977
2016
Q1 		$623K Hold
40,033
– – ﹤0.01% 965
2015
Q4 		$642K Hold
40,033
– – ﹤0.01% 991
2015
Q3 		$478K Hold
40,033
– – ﹤0.01% 1048
2015
Q2 		$569K Hold
40,033
– – ﹤0.01% 1074
2015
Q1 		$576K Hold
40,033
– – ﹤0.01% 1070
2014
Q4 		$560K Hold
40,033
– – ﹤0.01% 1126
2014
Q3 		$521K Hold
40,033
– – ﹤0.01% 1209
2014
Q2 		$560K Hold
40,033
– – ﹤0.01% 1214
2014
Q1 		$664K Buy
+40,033
New +$670K ﹤0.01% 1194

Other funds holding NRC

Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Royce & Associates's NRC Position: Q4 2024 in Review

Royce & Associates sold out of NRC Health Common Stock (NRC) in Q4 2024, closing a stake of 61,581 shares — an estimated $1.41M sold.

Royce & Associates first reported a position in NRC in Q1 2014 and held it in 43 quarters. The position peaked at $12.5M in Q3 2019. 133 funds tracked by Wall St. Rank hold NRC as of Q4 2024.

  • Royce & Associates reported no remaining NRC Health Common Stock position as of Q4 2024 after selling out during the quarter.
  • Royce & Associates sold 61,581 NRC Health Common Stock shares in Q4 2024, an estimated $1.41M.
  • Royce & Associates first reported a position in NRC Health Common Stock in Q1 2014 and held it in 43 quarters.
  • Royce & Associates's NRC Health Common Stock position peaked at $12.5M in Q3 2019.
  • 133 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q4 2024.

Based on Royce & Associates's 13F filing for Q4 2024, filed 10 Feb 2025.